A strong

Investment

Zur Rose Group is ideally positioned to deliver on the eRx opportunity in Germany and execute its strategy to create Europe's leading Healthcare Ecosystem. This will enable everyone to manage their health in one click.

PLACEHOLDER:

This is where the iframe with the stock charts from EQS would be located.

Today's share price
A convincing

Investment Case

The Zur Rose Group is gradually evolving from a pure e-commerce pharmacy to a comprehensive healthcare service and healthtech provider. We will become the European healthcare ecosystem by pursuing our vision of creating a world where everyone can manage their health in one click.

Our case for investment in more detail

Large market – low online penetration

#1 position: size, brand, tech, know-how

eRx Opportunity

Ecosystem Ramp-up

Growth story

From left: Thomas Schneider, Florian Seubert, Andréa Belliger, Walter Oberhänsli, Stefan Feuerstein, Christian Mielsch, Volker Amelung
A brief

Zur Rose factsheet

Zur Rose Group is Europe's undisputed #1 e-commerce pharmacy and it is our determined ambition to build the premier healthcare ecosystem in Europe. In addition we are also the market leader in Southern Europe for consumer health, beauty and personal care products. The group is broadly positioned internationally with a number of strong brands, including Germany's best-known online pharmacy, DocMorris.

More key facts
0 #1

Europe’s largest online pharmacy

0 1752

Million CHF external revenue in 2020

0 >11

Million active customers

0 2200

Employees

Share Information

Zur Rose Group AG has been listed on the stock exchange since July 6, 2017. The shares are traded on the SIX Swiss Exchange in the International Reporting Standard.

Read more

Bond Information

Key information on our outstanding Bonds and Convertible Bonds. 

Read more

Publications

Find all the Zur Rose Group Publications and Financial Reports.

Read more

Financial Analysts

Here you will find a list of analysts who regularly cover the Zur Rose Group and publish their own research reports.

Read more

General Shareholder Meeting

A critical milestone every year for the Zur Rose Group is the General Meeting of Shareholders. An Annual General Meeting is held each year within six months of the end of the financial year.

Read more

Corporate Governance

Comprehensive details about our Corporate Governance & Shareholder Structure.

Read more

Financial Calendar

Reporting Dates & Investor Events. 

Read more

Press Releases

Find all Press Releases in the News Section.

Press Releases

Any questions?

Have a question? Want to know more? Feel free to get in touch with us.

You can find specific contact information here

All contacts
Christoph Herrmann
Head of Investor Relations